Chlamydial genomics: insights into a recalcitrant pathogen

Description

Chlamydiae are obligate intracellular bacterial pathogens that cause a range of mammalian diseases, including the most common human sexually transmitted infections and trachoma (infectious blindness). Human disease arises by adverse host inflammatory reactions that induce tissue damage & scarring. Despite the global morbidity caused by chlamydial infections, relatively little is known about disease
mechanisms. Chlamydia are genetically intractable as replication outside of the host cell is not yet possible and there are no practical tools for routine genetic manipulation, making genome-scale approaches critical to the understanding of this major human and veterinary pathogen.

Biography
Garry Myers completed his PhD on chlamydial biology in 1998 at the University of Sydney (Faculty of Medicine) via the Menzies School of Health Research (Darwin, NT). Following postdoctoral training at The Institute for Genome Research (TIGR) in Rockville, Maryland, working on microbial genomics and pathogenesis, he joined the TIGR Faculty. In 2007, along with twelve other TIGR Faculty, he was a co-founder of the Institute for Genome Sciences at the University of Maryland School of Medicine (Baltimore, Maryland). In June 2014, he relocated to the ithree Institute at the University of Technology, Sydney. His research interests are focused upon the application of genomic-scale tools to bacterial pathogens and the host response.

Date & time

1–2pm 31 May 2018

Location

RN Robertson Building #46
Eucalyptus Seminar Room S2.05

Speakers

Associate Professor Garry Myers - ithree Institute, University of Technology Sydney - Host - Denisse Leyton - Matthew Johnson

Contacts

 Susan Howitt
 61 (0)2 6125 4356

Updated:  15 August 2018/Responsible Officer:  Director RSB/Page Contact:  Webmaster RSB